Sivik Global Healthcare LLC

Sivik Global Healthcare LLC reported 35 holdings worth US$175M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Oct 13, 2026

Sivik Global Healthcare LLC reported 35 holdings worth US$175M as of Sep 30, 2026. Largest: Humana Inc., Johnson & Johnson and Merck & Company, Inc. Filed Oct 13, 2026 (Form 13F).

Holdings
35
Value as reported
US$175M

The filing in full

CompanySharesValue as reported% of portfolio
Humana Inc.17,700US$6.75M3.9%
Johnson & Johnson24,000US$6.35M3.6%
Merck & Company, Inc.40,000US$5.81M3.3%
Abbvie Inc.22,000US$5.75M3.3%
Thermo Fisher Scientific Inc8,500US$5.74M3.3%
Cardinal Health, Inc.25,000US$5.56M3.2%
Mckesson Corporation6,500US$5.55M3.2%
Danaher Corporation25,000US$5.54M3.2%
Unitedhealth Group Incorporated15,000US$5.51M3.1%
Vertex Pharmaceuticals Incorporated10,500US$5.49M3.1%
Elevance Health, Inc.14,000US$5.44M3.1%
Abbott Laboratories55,000US$5.44M3.1%
Cencora, Inc.18,000US$5.4M3.1%
Agilent Technologies, Inc.30,000US$5.17M3.0%
Centene Corporation80,000US$4.97M2.8%
Eli Lilly And Company4,230US$4.89M2.8%
Encompass Health Corporation40,000US$4.86M2.8%
Revvity, Inc.30,000US$4.59M2.6%
Waters Corporation10,000US$4.39M2.5%
Bruker Corporation65,000US$4.21M2.4%
Edwards Lifesciences Corporation45,000US$3.88M2.2%
Repligen Corporation20,000US$3.84M2.2%
Mettler-toledo International, Inc.2,500US$3.78M2.2%
Gilead Sciences, Inc.25,000US$3.73M2.1%
The Cigna Group13,203US$3.59M2.1%
Biogen Inc.15,000US$3.39M1.9%
Bio-rad Laboratories, Inc.8,000US$3.02M1.7%
Avantor, Inc.175KUS$2.63M1.5%
Moderna, Inc.10,000US$1.93M1.1%
Argenx Se2,000US$1.92M1.1%
Madrigal Pharmaceuticals, Inc.2,500US$1.26M0.72%
Twist Bioscience Corporation1,128US$218K0.12%
Intuitive Surgical, Inc.0US$00.00%
Regeneron Pharmaceuticals, Inc.0US$00.00%
Smith & Nephew Plc0US$00.00%
Stryker Corporation0US$00.00%
Tenet Healthcare Corporation0US$00.00%
Universal Health Services, Inc.0US$00.00%
Boston Scientific Corporation0US$00.00%
Cvs Health Corporation0US$00.00%
Globus Medical, Inc.0US$00.00%

Source

View original at SEC

Related